𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck

✍ Scribed by Anibal Drelichman; Glenn Cummings; Muhyi Al-Sarraf


Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
381 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combination chemotherapy with methotrexa
✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 449 KB πŸ‘ 1 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

A phase II trial of cisplatin, methotrex
✍ Francesco Caponigro; Pasquale Comella; Paolo Marcolin; Francesco Russo Spena; Ma πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

## Background: Induction chemotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (scchn) might improve survival with respect to radiation therapy alone. furthermore, chemotherapy represents the only therapeutic option in metastatic head and neck carcinoma. ## Methods:

Alternating chemoradiotherapy versus par
✍ Renzo CorvΓ²; Marco Benasso; Giuseppe Sanguineti; Rita Lionetto; Almalina Bacigal πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 1 views

## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the